Gene · 10397
Papers3,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dissecting the effects of androgen deprivation therapy on cadherin switching in advanced prostate cancer: A molecular perspective. | Oncol Res | 2022 | 37305018 | PubTator, text mining | PubMed |
| CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration. | Front Oncol | 2022 | 36713580 | PubTator, text mining | PubMed |
| A cellular senescence-related genes model allows for prognosis and treatment stratification of hepatocellular carcinoma: A bioinformatics analysis and experimental verification. | Front Genet | 2022 | 36712870 | PubTator, text mining | PubMed |
| Ferroportin depletes iron needed for cell cycle progression in head and neck squamous cell carcinoma. | Front Oncol | 2022 | 36698390 | PubTator, text mining | PubMed |
| Construction and validation of a prognostic model for hepatocellular carcinoma: Inflammatory ferroptosis and mitochondrial metabolism indicate a poor prognosis. | Front Oncol | 2022 | 36686830 | PubTator, text mining | PubMed |
| Relationship between serum NDRG3 and papillary thyroid carcinoma. | Front Endocrinol (Lausanne) | 2022 | 36619553 | PubTator, text mining | PubMed |
| Repurposed Drugs in Gastric Cancer. | Molecules | 2022 | 36615513 | PubTator, text mining | PubMed |
| Multifaceted Pharmacological Potentials of Curcumin, Genistein, and Tanshinone IIA through Proteomic Approaches: An In-Depth Review. | Cancers (Basel) | 2022 | 36612248 | PubTator, text mining | PubMed |
| Human Placental Endothelial Cell and Trophoblast Heterogeneity and Differentiation Revealed by Single-Cell RNA Sequencing. | Cells | 2022 | 36611882 | PubTator, text mining | PubMed |
| Prospective mode of action of Ivermectin: SARS-CoV-2. | Eur J Med Chem Rep | 2022 | 36593981 | PubTator, text mining | PubMed |
| Analysis of the regulatory mechanisms of prognostic immune factors in thyroid cancer. | Front Oncol | 2022 | 36591507 | PubTator, text mining | PubMed |
| Systematic Analysis of Cellular Signaling Pathways and Therapeutic Targets for SLC45A3:ERG Fusion-Positive Prostate Cancer. | J Pers Med | 2022 | 36579559 | PubTator, text mining | PubMed |
| Altered sulfation status of FAM20C-dependent chondroitin sulfate is associated with osteosclerotic bone dysplasia. | Nat Commun | 2022 | 36572689 | PubTator, text mining | PubMed |
| N-myc downstream regulated gene 1 inhibition of tumor progression in Caco2 cells. | World J Gastrointest Oncol | 2022 | 36568939 | PubTator, text mining | PubMed |
| Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma. | Front Genet | 2022 | 36568396 | PubTator, text mining | PubMed |
| iPSC-Derived Macrophages: The Differentiation Protocol Affects Cell Immune Characteristics and Differentiation Trajectories. | Int J Mol Sci | 2022 | 36555728 | PubTator, text mining | PubMed |
| Studying Peptide-Metal Ion Complex Structures by Solution-State NMR. | Int J Mol Sci | 2022 | 36555599 | PubTator, text mining | PubMed |
| Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer. | Cancers (Basel) | 2022 | 36551580 | PubTator, text mining | PubMed |
| Activation of OSM-STAT3 Epigenetically Regulates Tumor-Promoting Transcriptional Programs in Cervical Cancer. | Cancers (Basel) | 2022 | 36551576 | PubTator, text mining | PubMed |
Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment. | Funct Integr Genomics | 2022 | 36536232 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10397/papers?page=25